Seven Weeks On, Still No China Generic Of Pfizer's Viagra Drug Sold
This article was originally published in PharmAsia News
Although Pfizer's China patent for its best-selling erectile dysfunction drug Viagra (sildenafil) expired more than seven weeks ago, the nation's drug makers have yet to get a generic on the market.
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.